newsfilter
← Latest News
GlobeNewswire·

Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update

NEW YORK, July 30, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (Anavex or the Company) (NASDAQ:AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous